The largest database of trusted experimental protocols
> Chemicals & Drugs > Organic Chemical > Sephadex G 75

Sephadex G 75

Sephadex G 75 is a porous, cross-linked dextran gel used for size-exclusion chromatography, typically in the molecular weight range of 3,000-80,000 Da.
It is commonly employed for the purificattion and separation of proteins, nucleic acids, and other macromolecules.
PubCompare.ai can help optimize your Sephadex G 75 research by comparing protocols from literature, preprints, and patents to identify the best methods and products, enhancing reproducibility and accuracy.
Get the most out of your Sephadex G 75 experiments with this AI-driven tool.

Most cited protocols related to «Sephadex G 75»

Fluxes of H+ or Cl were followed by continuous recording, with ion-specific electrodes, in suspensions of liposomes reconstituted with CLC-ec1. Voltage from the electrodes was fed to an Orion 701A high-sensitivity pH meter (Ebay.com) and digitized at 5–10 Hz by a DI-70 datalogger (DATAQ Instruments). Inward proton pumping driven by an outward Cl gradient was assayed as described previously (Accardi and Miller, 2004 (link)), using a glass pH electrode to follow H+ uptake in a lightly buffered suspension. After thawing, liposomes (2.5 μg/mg protein density) loaded with 300 mM KCl, 25 mM CPi, pH 4.8, were extruded 21 times through a 400-nm membrane filter (Nguitragool and Miller, 2006 (link)) and were then centrifuged through Sephadex G-50 (100-μl sample per 1.5 ml column) equilibrated with proton-pumping buffer (PPB), 290 mM K-isethionate, 10 mM KCl, 2 mM citrate, pH 5.2, and diluted 10-fold into PPB in a 2-ml stirred cell fitted with a pH electrode. Proton uptake was initiated by addition of 1 μM valinomycin (Vln) and collapsed by FCCP (2 μM). Proton efflux experiments were set up analogously, using liposomes loaded with 300 mM KCl, 25 mM citrate/25 mM MES, pH 4.5, and suspended in 300 mM KCl, 1 mM citrate/MES pH 6.5.
Net Cl efflux was similarly followed with Ag/AgCl electrodes in a stirred cell temperature-controlled to 25°C. Electrodes were constructed from silver wire cleaned overnight in concentrated HNO3 and coated with AgCl by immersion in Clorox bleach or 0.1 M FeCl3 solution. Liposomes reconstituted with 0.03–4 μg/mg CLC-ec1, and loaded with 300 mM KCl, 25 mM citrate-NaOH, pH 4.5, were extruded and centrifuged through Sephadex G-50 equilibrated in Cl dump-buffer (CDB), 300 mM K-isethionate, 1 mM KCl, 25 mM citrate, pH 4.5. The sample containing 1.2 mg lipid was added, and KCl efflux was evoked by Vln/FCCP. After 1–3 min, 50 mM octylglucoside detergent was added to release all trapped Cl. The electrode voltage signal, V(t), zeroed before initiating the efflux, was converted to the increase in Cl concentration, Δc(t), above the initial concentration c(0) by: and α, an electrode-imperfection factor (of unknown origin) determined by calibrating with 75 μM Cl at the beginning of each experiment, falls in the range 0.93 ± 0.03. This time course was fit to a two-component relaxation, one for the fraction (1 − fo) of liposomes containing transporters, the other for the fraction (fo) devoid of protein: where ΔcT, the total concentration of Cl released in the experiment (determined directly by detergent addition), typically reflects an increase of 0.15–0.2 mM over the 1 mM Cl present before the efflux. Here, kt and kL are the rate constants for Cl flux through the transporter and for the background leak through the liposome membrane, respectively. This background leak was measured in separate experiments on protein-free liposomes to be 5.7 ± 0.5 × 10−4 s−1, typically 50-fold lower than the transporter-mediated rate constant. For reasons explained in the text, we report the inverse of kt as the useful transporter-mediated kinetic parameter, denoted the “average time constant,” 〈τ〉. Experiments were temperature controlled at 25°C.
Publication 2007
KcsA was expressed in E. coli and purified on Ni2+ affinity columns as described (Heginbotham et al. 1997; MacKinnon et al. 1998). The purified channel was eluted in 400 mM imidazole at 1–5 mg/ml protein concentration quantified by the extinction coefficient at 280 nm (Heginbotham et al. 1998). Immediately after purification, KcsA was reconstituted into liposomes at room temperature as follows. A micellar solution of phospholipids (7.5 mg/ml POPE, 2.5 mg/ml POPG) and 34 mM CHAPS in reconstitution buffer (450 mM KCl/10 mM HEPES/4 mM N-methylglucamine, pH 7.0) was prepared as described (Heginbotham et al. 1998), and KcsA protein was added to final concentrations of 2.5–10 μg/ml, according to the number of channels per liposome desired. After 20–30 min incubation, 400 μl of the mixture was passed down a 20–ml Sephadex G-50 (fine) column equilibrated with reconstitution buffer. Liposomes eluted in the void volume with a dilution of approximately threefold and were stored in 75-μl aliquots at −80°C for up to 3 mo.
Publication 1999
1-palmitoyl-2-oleoylphosphatidylethanolamine 3-((3-cholamidopropyl)dimethylammonium)-1-propanesulfonate ATP8A2 protein, human Buffers Escherichia coli Extinction, Psychological HEPES imidazole Liposomes Meglumine Micelles Phospholipids Proteins sephadex G 50 Technique, Dilution Urination

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2011
Biuret Cells Crystallography DEAE Sephadex Dialysis Dialysis Solutions Electrophoresis Escherichia coli Extinction, Psychological Methanol Molar Mutant Proteins Palmitic Acid Plasmids Proteins sephadex G 100 Sodium Chloride Sulfate, Ammonium tricine Tromethamine

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2019
1H NMR Carbon-13 Magnetic Resonance Spectroscopy Chromatography Lincomycin Mass Spectrometry Methanol Optical Rotation Pressure Resins, Plant sephadex G 25 Silica Gel Solvents Sulfuric Acids Toluene Ultraviolet Rays

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2019
1H NMR Carbon-13 Magnetic Resonance Spectroscopy Chromatography Lincomycin Mass Spectrometry Methanol Optical Rotation Pressure Resins, Plant sephadex G 25 Silica Gel Solvents Sulfuric Acids Toluene Ultraviolet Rays

Most recents protocols related to «Sephadex G 75»

After ammonium sulfate precipitation and desalting of proteins, the highest protein concentration of dialyzed samples was subjected to a column (diameter: 1.5 cm, length: 30 cm, Bio-Rad, Hercules, CA, USA) containing Sephadex G-75 as the stationary phase, and in another trial, the column contained Sephadex G-50. The column was eluted with citrate buffer, pH 5. The eluted solution was collected in Cuvette tubes as fractions, each of 1 mL in size. Each fraction was used to measure dissolved protein concentration at 280 nm, enzyme activity in U/mL, and specific activity in U/mg protein as previously described [35 ,36 (link)].
Full text: Click here
Publication 2024
Salinicola tamaricis BGN2 was grown in the optimized medium; the cell (fermented) broth was centrifuged (6,000 rpm, 15 minutes, 4°C). The cell-free culture supernatant was sequentially precipitated with an increasing ammonium sulfate concentration. Solid ammonium sulfate was added to cell-free 500 ml of the fermented broth (70% saturation) with acetone (70%). The sample was subjected to a centrifugation process and precipitation was collected. The concentrated protein precipitate was collected by centrifugation at 10,000 rpm for 15 minutes at 4°C. Later, the protein precipitate was dissolved in 5 ml glycine-NaOH buffer (pH 10.0) and dialyzed for 12-14 hours using glycine-NaOH buffer (pH 10.0). The dialyzed protein samples were further fractionated and purified by using Sephadex-G-75 The gel chromatography matrix (Sephadex G-75) was soaked in sterile distilled water for 10-12 hours. The swollen gel matrix beads were removed from the gel slurry and filled into a glass column (100 × 2.5 cm) and with sintered filter was placed at the bottom. Care was taken to make the column free from air bubbles while preparing the gel pack into the column. The packed gel matrix column was saturated and equilibrated with 50 mM Tris-HCl buffer of pH 10.0. The dialyzed and ion exchange column purified protein preparation was loaded onto the Sephadex G-75 column and eluted with 50 mM Tris-HCl buffer of pH 10.0 at a flow rate of 3.0 ml per 5 minutes. The partially purified enzyme from the earlier step was then subjected to gel filtration chromatography on a Sephadex G-75 column (100 × 2.5 cm) equilibrated with 50 mM Tris-HCl buffer of pH 10.0 containing 0.5% Triton X-100. Sample fractions (5 ml) were collected using 50 mM Tris-HCl buffer of pH 10 with a flow rate of 12 ml/hour. Furthermore, the fractions were analyzed for enzyme (protease) activity. The fraction (11) (link)(12) (link)(13) (14) (15) (16) (link)(17) (link)(18) (link)(19) (link)(20) showing protease activities were pooled and further analyzed for total protein content and enzyme activity. As explained above, the eluted samples' protein concentration and protease activity were determined. Active protease fractions were pooled together and concentrated by lyophilization for enzyme characterization studies [4] (link).
Publication 2024
The air-dried embryos of N. nucifera seeds (19 kg) were extracted in 80% EtOH
for 2 d three times by cold soaking. The vacuo concentration of the
EtOH extract yielded 5 kg of residue. This material was suspended
in H2O and subjected to extraction using CH2Cl2. The resulting CH2Cl2 extract
(700 g) underwent a series of purification steps utilizing EtOAc,
EtOAc–MeOH (15:1), EtOAc–MeOH (1:1), and MeOH on a silica
gel column, generating four fractions (Fr.1–Fr.4). These fractions
were analyzed by TLC for alkaloid detection. The alkaloid-rich Fr.4
(200 g) eluted through silica gel CC with EtOAc–MeOH–H2O (15:2:1, 10:2:1, and 7:2:1, v/v/v) yielded 11 fractions
(Fr.4-1–11). Fr.4-11 (42 g) was further separated via silica
gel CC using CHCl3–MeOH (35:1, 25:1, 15:1, 10:1,
5:1, and 1:1, v/v) containing 0.1% NH3 to afford six subfractions
(Fr.4-11-1–6). Fr.4-11-1 (4.5 g) was successively separated
by chromatography on a Sephadex LH-20 (MeOH) and subjected to preparative
HPLC using CH3CN–H2O (5:95–25:75,
v/v, 12.0 mL/min, 30 min) with 0.01% formic acid to yield 1 (16.0 mg). Fr.4-11-5 (110 mg) was also separated by chromatography
on a Sephadex LH-20 (MeOH) and subsequently subjected to preparative
HPLC (CH3CN–H2O, 5:95–25:75, v/v,
containing 0.01% formic acid, 12.0 mL/min, 30 min) to afford 1.8 mg
of 4 and 2.9 mg of 5. Fr.4-10 (9.8 g) was
separated by silica gel CC and eluted using CHCl3–MeOH
(35:1, 25:1, 15:1, 10:1, 5:1, and 1:1, v/v) containing 0.1% NH3, affording six subfractions (Fr.4-10-1–6). Fr.4-10-4
was consecutively separated on a Sephadex LH-20 column (MeOH), eluted
through silica gel CC using CHCl3–MeOH (35:1–5:1,
v/v) containing 0.1% NH3, and subjected to preparative
HPLC using CH3CN–H2O (5:95–25:75,
v/v, 12.0 mL/min, 30 min) with 0.01% formic acid, to give 9 (23.0 mg), 10 (50.0 mg), 11 (7.0 mg),
and 12 (12.0 mg). Fr.4-10-5 (1.2 g) was separated by
chromatography on a Sephadex LH-20 column (MeOH) and afterward subjected
to preparative HPLC (CH3CN–H2O, 5:95–25:75,
v/v, containing 0.01% formic acid, 12.0 mL/min, 30 min) to yield 2 (3.7 mg), 3 (10 mg), 6 (2.7 mg), 7 (60.0 mg), and 8 (40.0 mg).
Publication 2024

Example 1

Initial evaluation of the hemostatic properties of a composition comprising an anion exchanger and a calcium salt was carried out in an in-vivo heparinized porcine spleen circular punch model as described above, using DEAE covalently bound to Sephadex (DEAE-SEPHADEX™) as the anion exchanger. In this experiment, the punch size was 4 mm diameter, 2 mm depth. A compression time of 30 or 60 seconds was used following application. DEAE SEPHADEX™ A-50 was tested at two concentrations. In this experiment, the Post-Application Bleeding Intensity was evaluated qualitatively.

The following compositions (see elaboration in Table 1 above) were evaluated for their hemostatic efficacy:

    • 1. DEAE SEPHADEX™ A-50, prepared as 10% w/v slurry in 20 mM CaCl2 solution, (0.5 ml contains 50 mg DEAE SEPHADEX™ A-50) (30 seconds compression time);
    • 2. DEAE SEPHADEX™ A-50, prepared as 6.6% w/v slurry in 20 mM CaCl2 solution, (0.5 ml contains 33 mg DEAE SEPHADEX™ A-50) (60 seconds compression time);
    • 3. SEPHADEX™ G-75 Superfine, prepared as 10% w/v slurry in 20 mM CaCl2 solution, (0.5 ml contains 50 mg per SEPHADEX™ G-75 Superfine) (60 seconds compression time);
    • 4. SEPHADEX™ G-50 Medium, prepared as 10% w/v slurry in 20 mM CaCl2 solution, (0.5 ml contains 50 mg SEPHADEX™ G-50 Medium) (60 seconds compression time);
    • 5. Commercial gelatin hemostat prepared as a slurry (0.5 ml contains 55 mg gelatin) (60 seconds compression time).

All four SEPHADEX™ samples comprise the same base polymer, cross-linked dextran. Compositions 1-4 were provided as powders, from which slurries were prepared as described in the Table 1 above. A commercial gelatin flowable hemostat was used as control.

It was found that SEPHADEX™ G-50 Medium, SEPHADEX™ G-75 Superfine and commercial gelatin hemostat, failed to stop the bleeding, i.e. no reduction in bleeding intensity was observed (results not shown).

Surprisingly, DEAE SEPHADEX™ A-50 reduced the bleeding at all tested compression times. Following the application of DEAE SEPHADEX™ A-50, the spleen was manually manipulated by folding the organ from both sides. No re-bleeding occurred at either of the tested concentrations and following the two different compression times (results not shown). Since hemostasis only occurred in the matrix supplemented with DEAE groups it was concluded that the hemostatic effect was due the presence of the DEAE groups.

FIG. 1 shows an exemplary result obtained using DEAE SEPHADEX™ A-50 10% (w/v) and commercial gelatin. As shown in the figure, commercial gelatin hemostat failed to stop the bleeding after a compression time of 60 seconds, whereas DEAE SEPHADEX™ A-50 10% (w/v) successfully stopped the bleeding even following a shorter compression time of 30 seconds.

Example 2

In the following Example, the effect on hemostasis of each of the components of a composition comprising an anion exchanger and a calcium salt was evaluated, separately and in combination, using an in-vivo heparinized porcine liver circular punch model, as described above. This experiment identifies which of the components of the composition are required for achieving hemostasis.

The preparation of each composition is described in Table 1 above. Compression time is listed in Table 2 below. In this experiment, the Initial Bleeding Intensity and Post-Application Bleeding Intensity were evaluated according to the 0-5 scale.

The following compositions were evaluated:

    • 1. DEAE SEPHADEX™ A-50, prepared as 8% w/v slurry in 20 mM CaCl2 solution (0.5 ml contains 40 mg DEAE SEPHADEX™ A-50);
    • 2. Commercial gelatin hemostat, prepared as a slurry (0.5 ml contains 55 mg gelatin);
    • 3. Commercial gelatin hemostat with thrombin, prepared as a slurry (0.5 ml contains 55 mg gelatin);
    • 4. SEPHADEX™ G-50 Medium, prepared as 14% w/v slurry in 20 mM CaCl2 solution (0.5 ml contains 70 mg SEPHADEX™ G-50 Medium).
    • 5. DEAE SEPHADEX™ A-50, prepared as 8% w/v slurry in 20 mM NaCl solution (0.5 ml contains 40 mg DEAE SEPHADEX™ A-50);
    • 6. SP SEPHADEX™ C-50, prepared as 8% w/v slurry in 20 mM CaCl2 solution (0.5 ml contains 40 mg SP SEPHADEX™ C-50);
    • 7. QAE SEPHADEX™, prepared as 8% w/v slurry in 20 mM CaCl2 solution (0.5 ml contains 40 mg QAE SEPHADEX™);
    • 8. DEAE SEPHACEL™, prepared as a slurry (100 mg); and
    • 9. TOYOPEARL DEAE-650M™, prepared in powder form (100 mg).

The compression time following the application of each tested composition, and the bleeding intensity results are shown in Table 2. Bleeding Intensity Reduction was calculated by subtracting the Post-Application Bleeding Intensity from the Initial Bleeding Intensity.

TABLE 2
Effect of tested compositions in reduction of
bleeding intensity (liver bleeding model)
Compres-Bleeding Intensity
Calciumsion timeIni-PostReduc-
Tested CompositionSalt(seconds)tialApplicationtion*
DEAE+60505
SEPHADEX ™+30303
A-50+10413
(8% w/v)+0211
*Calculated by subtracting the Post Application Bleeding Intensity from the Initial Bleeding Intensity.

TABLE 3
Effect of tested compositions in reduction of
bleeding intensity (liver bleeding model)
Bleeding Intensity
CalciumIni-PostReduc-
Tested CompositionSalttialApplicationtion*
DEAE SEPHACEL ™+303
(100 g slurry)
TOYOPEARL DEAE-650M ™+404
(100 mg powder)
QAE SEPHADEX ™+431
(8% w/v)
DEAE SEPHADEX ™ A-50330
(8% w/v)
with 20 mM NaCl
SEPHADEX ™ G50+330
(14% w/v)
SP SEPHADEX ™ C-50+330
(8% w/v)
Commercial gelatin+303
hemostat with thrombin
Commercial330
gelatin hemostat
*Calculated by subtracting the Post Application Bleeding Intensity from the Initial Bleeding Intensity.

In general, it can be seen, that a composition comprising an anion exchanger, such as DEAE bound to a matrix, together with a calcium salt, lead to complete hemostasis (see Table 2 for DEAE SEPHADEX™ A-50, DEAE SEPHACEL™, and TOYOPEARL DEAE-650M™, all containing a calcium salt). These compositions substantially lead to complete hemostasis regardless of the specific matrix used. For example, matrices such as SEPHADEX™, SEPHACEL™ and TOYOPEARL™ (dextran, cellulose and hydroxylated methacrylic polymer, respectively) had a similar effect in reducing the bleeding intensity.

More particularly, DEAE SEPHADEX™ A-50 8% w/v in CaCl2 was able cease bleeding after 60, and 30 seconds of compression. The results also showed DEAE SEPHADEX™ A-50 (8% w/v) application could be used, without compression, to reduce bleeding intensity (Table 2).

The hemostatic capabilities of a composition comprising DEAE SEPHADEX™ A-50 and a calcium salt exhibited similar efficacy to that of commercial gelatin hemostat with thrombin, when using the same compression time (30 seconds), and even with only 10 seconds of compression. However, the hemostatic capability of a hemostat based on an anion exchanger comprising DEAE bound to a matrix, and a calcium salt, was substantially superior to that of commercial gelatin hemostat in the absence of a biologically active component, such as thrombin.

As shown in Table 3, a composition comprising DEAE SEPHADEX™ prepared with NaCl, and lacking a calcium salt produced no reduction in bleeding intensity, such that it can be concluded that the sample was not effective in stopping the bleeding.

When evaluating the impact of the ion exchange group on the hemostatic capability, it was shown that SP SEPHADEX™ containing an anionic group, sulfopropyl (SP) with a calcium salt, did not reduce the bleeding intensity. In other words, a material with a negative (SP) group, instead of a positive (DEAE) group was not effective as a hemostat.

It was further shown that a quaternary aminoethyl, QAE SEPHADEX™ with a calcium salt was able to reduce bleeding intensity.

It was also shown, as in Example 1, that the matrix alone, in the absence of a functional group (SEPHADEX™ G-50 with a calcium salt but without DEAE groups) had no hemostatic efficacy.

The results show that use of a composition comprising DEAE groups bound to a matrix in presence of a calcium salt effectively achieved hemostasis.

The results also showed that compression time of 30 and 60 seconds following DEAE SEPHADEX™ A-50 (8% w/v) application resulted in complete hemostasis and therefore the TTH was defined as 30 seconds.

It was thus shown that an anion exchanger such as DEAE bound to a matrix together with a calcium salt provided complete hemostasis. This result was obtained regardless of the matrix used. The results are comparable to those obtained when using a commercial hemostat such as gelatin with thrombin.

It was found that QAE SEPHADEX™ together with a calcium salt reduced bleeding.

A composition devoid of a calcium salt and/or a matrix had no effect on the bleeding intensity.

These results suggest that a composition comprising an anion exchanger and a calcium salt is effective as a hemostat.

Full text: Click here
Patent 2024
The extraction and determination of glucosinolates were conducted by Guo et al. [38 (link)]. Approximately 0.5 g of fresh sprouts were homogenized with 4 mL of boiled 75% methanol solution and extracted at 80 °C for 15 min. After the homogenates were centrifuged at 10,000× g for 10 min, the supernatant was flowed through DEAE Sephadex A-25 column to purity glucosinolates, then analyzed by HPLC system with a UV detection at 226 nm. The unit of glucosinolate content was expressed as μmol/g FW.
Full text: Click here
Publication 2024

Top products related to «Sephadex G 75»

Sourced in United States, Italy, United Kingdom, Germany
Sephadex G-75 is a gel filtration chromatography material produced by Merck Group. It is used for the separation and purification of proteins, peptides, and other biomolecules based on their size and molecular weight.
Sourced in Sweden, United States, United Kingdom
Sephadex G-75 is a size-exclusion chromatography medium used for the separation and purification of proteins, peptides, and other biomolecules based on their molecular size. It is composed of cross-linked dextran beads that provide a porous structure for the separation process. Sephadex G-75 is suitable for the fractionation of molecules with a molecular weight range of 3,000 to 70,000 daltons.
Sourced in United States
Sephadex G-75 is a gel filtration media used for the separation and purification of macromolecules, such as proteins and nucleic acids, based on their size and molecular weight. It is a cross-linked dextran polymer that forms a porous matrix, allowing smaller molecules to penetrate the pores while larger molecules are excluded, resulting in their separation.
Sourced in United States, Germany, United Kingdom, China, Italy, Japan, France, Sao Tome and Principe, Canada, Macao, Spain, Switzerland, Australia, India, Israel, Belgium, Poland, Sweden, Denmark, Ireland, Hungary, Netherlands, Czechia, Brazil, Austria, Singapore, Portugal, Panama, Chile, Senegal, Morocco, Slovenia, New Zealand, Finland, Thailand, Uruguay, Argentina, Saudi Arabia, Romania, Greece, Mexico
Bovine serum albumin (BSA) is a common laboratory reagent derived from bovine blood plasma. It is a protein that serves as a stabilizer and blocking agent in various biochemical and immunological applications. BSA is widely used to maintain the activity and solubility of enzymes, proteins, and other biomolecules in experimental settings.
Sourced in United States, Germany
Amberlite XAD4 is a polymeric adsorbent resin. It is a macroreticular, non-ionic, polystyrene-based resin.
Sourced in United States, Germany, United Kingdom, Italy, China, Japan, France, Canada, Sao Tome and Principe, Switzerland, Macao, Poland, Spain, Australia, India, Belgium, Israel, Sweden, Ireland, Denmark, Brazil, Portugal, Panama, Netherlands, Hungary, Czechia, Austria, Norway, Slovakia, Singapore, Argentina, Mexico, Senegal
Triton X-100 is a non-ionic surfactant commonly used in various laboratory applications. It functions as a detergent and solubilizing agent, facilitating the solubilization and extraction of proteins and other biomolecules from biological samples.
Sourced in United States, Italy, Germany
Cardiolipin is a phospholipid component found in the inner mitochondrial membrane. It plays a crucial role in the functioning of the electron transport chain and the production of adenosine triphosphate (ATP) within the mitochondria.
Sourced in Sweden, Japan, China, United States, Germany, United Kingdom, France, Italy, Canada
Sephadex LH-20 is a size-exclusion chromatography media developed by GE Healthcare for the separation and purification of a wide range of organic molecules, including proteins, peptides, nucleic acids, and small organic compounds. It is composed of cross-linked dextran beads and is designed for use in gravity-flow or low-pressure liquid chromatography applications.
Sourced in United States, Italy, Poland
L-carnitine is a naturally occurring compound that plays a crucial role in the metabolism of fats. It is primarily responsible for the transport of long-chain fatty acids into the mitochondria, where they can be used for energy production. This lab equipment product is an important component in various biochemical and metabolic research applications.
Sourced in United States
The BioLogic LP system is a versatile liquid chromatography system designed for laboratory applications. It features a small footprint and user-friendly interface, making it suitable for a variety of purification and analysis tasks. The system includes integrated pumps, valves, and a UV detector to provide automated control and real-time monitoring of the chromatographic process.

More about "Sephadex G 75"

Sephadex G-75 is a widely used porous, cross-linked dextran gel for size-exclusion chromatography, ideal for purifying and separating proteins, nucleic acids, and other macromolecules in the molecular weight range of 3,000-80,000 Da.
This versatile gel has many applications, including isolating bovine serum albumin (BSA), separating Amberlite XAD4 resin, and removing Triton X-100 detergent from cardiolipin samples.
Sephadex G-75 can also be used in conjunction with other chromatographic media, such as Sephadex LH-20, to purify compounds like L-carnitine.
The BioLogic LP system is a popular choice for automating and optimizing Sephadex G-75 column chromatography, ensuring consistent and reproducible results.
By comparing protocols from literature, preprints, and patents, the AI-driven tool PubCompare.ai can help researchers identify the best methods and products for working with Sephadex G-75, enhancing the accuracy and reproducibility of their experiments.
This valuable resource can help scientists get the most out of their Sephadex G-75 research, leading to more robust and reliable findings.